In diabetes, the increased PGE2 production from COX-2 activity significantly contributes to cellular dysfunction [8,26,99]; on the other hand, COX-2 inhibition prevents glucose-induced overproduction of VEGF-A in the retina [100,101]. Here, PTGS2 is linked to diabetes mellitus.